Prescription, OTC, and 510(k)-Exempt Are Different Regulatory Concepts

FDA classification, 510(k) exemption, and prescription or OTC status each serve different regulatory purposes. Understanding those distinctions is essential when evaluating state distributor-registration requirements.

Different Terms Answer Different Questions

Medical-device companies often use terms such as “Class I,” “510(k)-exempt,” “OTC,” and “prescription device” as though they describe the same regulatory status. They do not.

Each term answers a different question, and confusing them can lead a company to conclude incorrectly that state distributor registration is unnecessary.

FDA Classification Describes the Level of Regulatory Control

FDA classification describes the level of regulatory control generally required for the device type. Class I devices are ordinarily subject to general controls, Class II devices generally require general and special controls, and Class III devices generally require premarket approval.

Classification is primarily risk- and control-based. It does not, by itself, determine whether a device may be sold directly to consumers or whether a distributor must register with a state authority.

The Premarket Pathway Is a Separate Issue

A 510(k) is a premarket notification through which a manufacturer generally demonstrates substantial equivalence to a legally marketed predicate device.

Many Class I and some Class II device types are exempt from that submission requirement, subject to the limitations of the applicable exemption.

“510(k)-exempt” therefore means that a qualifying device may be marketed without obtaining a 510(k) clearance. It does not mean that the product is unregulated, exempt from all FDA requirements, or automatically suitable for unrestricted consumer sale.

Conditions of Sale and Use Form a Third Regulatory Axis

An OTC device is intended to be selected and used by a consumer without the supervision of a licensed practitioner.

A prescription device is one that is not safe for use except under the supervision of a practitioner licensed to direct its use and must meet the applicable prescription-device labeling and distribution conditions.

A device may also be intended exclusively for use by trained healthcare professionals or be subject to other restrictions on its sale, distribution, or use.

These Regulatory Concepts Can Overlap

These concepts can overlap in ways that are not intuitive. FDA recognizes OTC devices in more than one device class, including devices that require premarket review.

Conversely, FDA's classification regulations include prescription-use devices that are expressly 510(k)-exempt. For example, certain prescription interactive rehabilitation exercise devices are Class II but exempt from 510(k) requirements.

The absence of a 510(k)-clearance number therefore says little about whether the product is prescription-only, intended exclusively for professional use, or subject to controlled distribution.

State Rules Make the Difference

This distinction matters when assessing state registration. State boards of pharmacy and equivalent agencies apply their own statutes, definitions, and licensing categories.

A state may regulate all medical-device distributors, only distributors of prescription devices, distribution to patients pursuant to an order, or particular activities such as wholesale sale, storage, shipment, invoicing, or dispensing.

Those requirements are not ordinarily determined by whether the manufacturer submitted a 510(k).

Review Three Separate Questions for Every Product and State

A distributor should review at least three separate questions for every product and state:

• What is the FDA classification and product code?
• What premarket pathway applies, including any exemption limitations?
• How is the device labeled, sold, ordered, supplied, and used, and how does the state regulate those activities?

“510(k)-exempt” is not a licensing conclusion. It is only one fact within a broader federal and state regulatory analysis.

Build a Compliant State-Registration Strategy

MDD Options can assess how a device's FDA classification, premarket status, labeling, sales channel, and intended users interact with state distributor-registration requirements.

Where licensing gaps or operational constraints are identified, MDD Options can help structure a compliant market-entry plan and, through its Hybrid distribution model, provide the licensed commercial infrastructure needed to support sales while the manufacturer develops its own longer-term state-registration strategy.